Digbijay Mishra And Sushmi Dey

Stories by Digbijay Mishra And Sushmi Dey

Drug makers told to give pricing details in 10 days

Drug makers told to give pricing details in 10 days

Rediff.com   6 Jun 2014

The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.

Now, buy medicines and stents on EMI

Now, buy medicines and stents on EMI

Rediff.com   5 Jun 2014

The company did not respond to specific queries on the project's expansion.

Mallya to remain chairman of MCF board even after sell off

Mallya to remain chairman of MCF board even after sell off

Rediff.com   22 May 2014

The agreement says UB Group and Adventz will have the right of first refusal over each other's shares.

Indian drug cos to benefit as US expedites generic clearances

Indian drug cos to benefit as US expedites generic clearances

Rediff.com   12 May 2014

Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.

Zuari-Mangalore Chemicals stake sale deal gets bitter

Zuari-Mangalore Chemicals stake sale deal gets bitter

Rediff.com   25 Apr 2014

Poddar had earlier said he would sell his stake in Mangalore Chemicals to the highest bidder.

Novartis-Glaxo deal signals pharma firms don't have it easy

Novartis-Glaxo deal signals pharma firms don't have it easy

Rediff.com   24 Apr 2014

Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.

Novartis-GSK-Eli Lilly deal may affect Indian market

Novartis-GSK-Eli Lilly deal may affect Indian market

Rediff.com   23 Apr 2014

On Tuesday, Novartis agreed to buy GSK's oncology products business for $14.5 billion, while selling its vaccines business, excluding flu, to GSK for $7.1 billion.

ICAI to ban three auditors in Satyam case

ICAI to ban three auditors in Satyam case

Rediff.com   23 Apr 2014

ICAI has also imposed a fine of Rs 5 lakh on each of the three accused in Satyam case.

Ranbaxy buy in line with Sun's strategy

Ranbaxy buy in line with Sun's strategy

Rediff.com   17 Apr 2014

The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.

Regulatory pain for GSK's Crocin Advance

Regulatory pain for GSK's Crocin Advance

Rediff.com   28 Mar 2014

The NPPA letter was issued to GSK on Wednesday.

Consumers may have to pay more for insulin

Consumers may have to pay more for insulin

Rediff.com   21 Mar 2014

Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.

24 private hospitals get showcause notices

24 private hospitals get showcause notices

Rediff.com   20 Mar 2014

What started as a mere payment delay seems to have grown into a tussle between the government and leading private hospitals, empanelled under the Central Government Health Scheme.

Why is Novartis likely to lose Tiamulin drug licence?

Why is Novartis likely to lose Tiamulin drug licence?

Rediff.com   19 Mar 2014

Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.

Holi weekend splash for travel companies

Holi weekend splash for travel companies

Rediff.com   16 Mar 2014

Indian traveller is no longer satisfied with a single annual vacation, but is increasingly demanding multiple holidays and festive breaks offer an ideal opportunity.

Purnendu Chatterjee might head HPL

Purnendu Chatterjee might head HPL

Rediff.com   7 Mar 2014

Bankers of HPL too have endorsed the idea and are pitching hard for the chairmanship of Chatterjee.

US regulator urges USV to probe staff for inaccurate data reporting

US regulator urges USV to probe staff for inaccurate data reporting

Rediff.com   5 Mar 2014

The US Food and Drug Administration has asked USV to probe employees who might have been responsible for inaccurate data reporting.

Why is DLF again under competition watchdog's scanner?

Why is DLF again under competition watchdog's scanner?

Rediff.com   4 Mar 2014

CCI has accused realty player DLF of preparing one-sided agreement with home buyers

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com   27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

Scanner on Novartis for giving 'fake' documents

Scanner on Novartis for giving 'fake' documents

Rediff.com   10 Feb 2014

Swiss drug maker Novartis might face tough action from the country's drug regulator for allegedly giving fake documents while seeking renewal of registration for Tiamulin Hydrogen Fumerate (80 per cent granules), sources said.

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com   10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.